Michael John Tomsicek, Chief Financial Officer at CRISPR Therapeutics AG (CRSP), sold 17,448 shares at $87.33 ($1.5M) on 2020-08-03, disclosed to the SEC on 2020-08-05.
Open-market sale of $1.5M CRSP by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.25 | 6,552 | $565K | 37.3% |
| 2 | $87.33 | 5,448 | $476K | 31.4% |
| 3 | $87.33 | 5,448 | $476K | 31.4% |
| Total | $86.92 avg | 17,448 | $1.5M | 100% |
| Filing → |
| CRSP | SELL | 2020-09-03 | $1.4M | — | Filing → |
| CBST | SELL | 2014-08-18 | $26K | — | Filing → |
| CBST | SELL | 2014-05-14 | $34K | — | Filing → |